LEADER 02023nam  2200361   450 
001 9910583035003321
005 20230120002806.0
010   $a0-12-813039-3
035   $a(CKB)4100000006670312
035   $a(MiAaPQ)EBC5511118
035   $a(EXLCZ)994100000006670312
100   $a20180927d2019      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aLate-stage fluorination of bioactive molecules and biologically-relevant substrates /$fAl Postigo
210  1$aAmsterdam, Netherlands ;$aOxford, England ;$aCambridge, England :$cElsevier,$d2019.
215   $a1 online resource (498 pages) $cillustrations
311   $a0-12-812958-1 
330   $aLate-Stage Fluorination of Bioactive Molecules and Biologically-Relevant Substrates reviews how the use of these techniques on compounds with already known and relevant biological activity can provide new pharmaceutical leads with improved medicinal properties. The fluorination strategies discussed take into account both conventional and novel reagents, including nucleophilic, electrophilic, those of a radical nature, and diverse families of organic compounds, such as (hetero) aromatic rings and aliphatic substrates. Drawing on the authors' expert knowledge, this book provides researchers with a broad set of applicable methods to use in their work. Highlights the latest developments in the field in a concise volume. Provides details of key fluorinating reagents across diverse families of organic compounds. Explores the current applications and future potential of fluorine in drug development.
606   $aFluorination
615  0$aFluorination.
676   $a547.2
700   $aPostigo$b Al$0903317
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910583035003321
996   $aLate-stage fluorination of bioactive molecules and biologically-relevant substrates$92019435
997   $aUNINA